Antonio Zandona

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Molecular Docking

Cell Cycle Arrest

Endothelial Cells

Top Venues

International journal of molecular sciences

Pharmaceuticals (Basel, Switzerland)

Archives of toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Suzana Žunec, Donna Vadlja, Alma Ramić, Antonio Zandona, Nikola Maraković, Iva Brekalo, Ines Primožič, Maja Katalinić
Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability. International journal of molecular sciences 25 (1) (2023)
Suzana Žunec, Donna Vadlja, Alma Ramić, Antonio Zandona, Nikola Maraković, Iva Brekalo, Ines Primožič, Maja Katalinić
Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability. International journal of molecular sciences 25 (1) (2023)
Suzana Žunec, Donna Vadlja, Alma Ramić, Antonio Zandona, Nikola Maraković, Iva Brekalo, Ines Primožič, Maja Katalinić
Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability. International journal of molecular sciences 25 (1) (2023)
Dajana Gašo Sokač, Antonio Zandona, Sunčica Roca, Dražen Vikić-Topić, Gabriela Lihtar, Nikola Maraković, Valentina Bušić, Zrinka Kovarik, Maja Katalinić
Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands. International journal of molecular sciences 23 (21) (2022)
Antonio Zandona, Karla Jagić, Marija Dvoršćak, Josip Madunić, Darija Klinčić, Maja Katalinić
PBDEs Found in House Dust Impact Human Lung Epithelial Cell Homeostasis. Toxics 10 (2) (2022)
Ana Matošević, Anamarija Knežević, Antonio Zandona, Nikola Maraković, Zrinka Kovarik, Anita Bosak
Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Ana Matošević, Andreja Radman Kastelic, Ana Mikelić, Antonio Zandona, Maja Katalinić, Ines Primožič, Anita Bosak, Tomica Hrenar
Quinuclidine-Based Carbamates as Potential CNS Active Compounds. Pharmaceutics 13 (3) (2021)
Antonio Zandona, Gabriela Lihtar, Nikola Maraković, Katarina Miš, Valentina Bušić, Dajana Gašo-Sokač, Sergej Pirkmajer, Maja Katalinić
Vitamin B3-Based Biologically Active Compounds as Inhibitors of Human Cholinesterases. International journal of molecular sciences 21 (21) (2020)
Antonio Zandona, Maja Katalinić, Goran Šinko, Andreja Radman Kastelic, Ines Primožič, Zrinka Kovarik
Targeting organophosphorus compounds poisoning by novel quinuclidine-3 oximes: development of butyrylcholinesterase-based bioscavengers. Archives of toxicology 94 (9) (2020)